Medical News

RSS

DSS research survey reveals relationship between engagements, health literacy

DSS Research, the leader in market research for the health insurance industry, developed a proprietary set of metrics that gauge the level of engagement in health care on the part of the consumer. This quarter we added extra questions to further test the relationship between different literacy measures and the level of engagement amongst commercial and Medicare populations and the uninsured.

10 Aug 2010

Surveillance systems find no major disease outbreaks since Haiti quake; Media examine aid disbursements

Haitian and U.S. public health experts recently reported that two new surveillance systems set up in Haiti after the January earthquake showed that no major disease outbreaks had developed and that the new systems could be part of the foundation of the country's health system in the long term, Reuters reports. The findings were published Friday in the CDC's Morbidity and Mortality Weekly Report.

10 Aug 2010

Olympus America introduces new V-System for ERCP procedure

Olympus America Inc., a precision technology leader designing and delivering innovative solutions in medical and surgical products among other core business areas, today launched its new V-System. The new V-System combines Olympus' latest duodenoscope, the TJF-Q180V, with its unique V-System devices for the endoscopic retrograde cholangiopancreatography procedure.

From Evident Corporation - Life Sciences 10 Aug 2010

Three-year efficacy data on STELARA for psoriasis presented at American Academy of Dermatology meeting

New study findings showed that a majority of patients with moderate to severe plaque psoriasis who had a previous response to STELARA® (ustekinumab) sustained a clinical response for up to three years with continued treatment regardless of their body weight. Investigators also presented findings from an integrated safety analysis that included data from one Phase 2 and three Phase 3 trials in which treatment with STELARA demonstrated a favorable benefit-risk profile for up to three years of treatment, consistent with previous analyses.

10 Aug 2010

FDA approves human embryonic stem cells clinical trial for spinal cord injury treatment

Emerging Healthcare Solutions, Inc.: Last week, the US Food and Drug Administration gave their highly-anticipated approval for the first clinical trial using human embryonic stem cells (hESCs), which are the type of cells that can develop into all tissues of the body. Geron Corporation of Menlo Park, California, received the green light from the US FDA to use cells derived from hESCs to treat people with acute spinal cord injuries. Ten people will receive injections into the injury site of hESC-derived oligodendrocyte progenitor cells, which stimulate the growth of new and severed nerves and recoat damaged nerves with myelin. The hope is that the injections will help people recover function lost through injury, as seen in rodent studies in 2005.

10 Aug 2010

Older Americans suffer from full-blown depression: Report

Maureen Duffy's memories of her grandmother are cloudy. Not because of time, but by a condition that cast a shadow over the woman Duffy had visited as a child.

10 Aug 2010

Survey shows web users access social media sites in emergency situations

A new American Red Cross survey shows many web users would turn to social media to seek help for themselves or others during emergencies—and they expect first responders to be listening.The online survey asked 1,058 adults about their use of social media sites in emergency situations. It found that if they needed help and couldn't reach 9-1-1, one in five would try to contact responders through a digital means such as e-mail, websites or social media.

10 Aug 2010

Transcept Pharmaceuticals second-quarter net loss decreases to $2.06 million

Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced financial results for the three and six months ended June 30, 2010.

10 Aug 2010

CGI receive contract for chronic disease management system

eHealth Ontario and Infrastructure Ontario announced today that with the awarding of a contract to CGI Information Systems and Management Consultants Inc., a subsidiary of CGI Group Inc., work can begin on a chronic disease management system (CDMS) that will be used initially as a Diabetes Registry to manage diabetes care.

10 Aug 2010

Calif. considers reduction in funding for home care aides; Ill. union workers strike over health issues at uranium conversion plant

California, facing a $19.1 billion budget gap, is considering a reduction in funding that pays for home care aides for the disabled. It already cut funds last year. … Last month, the nation celebrated the 20th anniversary of the Americans With Disabilities Act … Now, though, gains made under the ADA are running into recession-battered state budgets.

10 Aug 2010

HHS: $250 million in grants available for New Access Points for delivery of primary health care services

U.S. Department of Health and Human Services Secretary Kathleen Sebelius announced today the availability of up to $250 million in grants for New Access Points for the delivery of primary health care services for underserved and vulnerable populations under the Health Center Program. The funds, made available by the Affordable Care Act, will be awarded by the Health Resources and Services Administration (HRSA).

10 Aug 2010

Epitherix identifies potent and selective multiple chemical scaffolds against colorectal carcinoma

Epitherix, LLC, a privately held company focused on the discovery and development of novel Wnt pathway small molecule inhibitors for epithelial and leukemic cancers, today announced that it has identified multiple chemical scaffolds that are potent and selective against colorectal carcinoma. "We're very encouraged by our in vitro and in vivo data, especially considering the difficulty in drugging this pathway to date," said Dr. Osman Kibar, CEO of Epitherix.

10 Aug 2010

Alnylam Pharmaceuticals reports significant progress in discovery of novel technologies for systemic delivery of RNAi therapeutics

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the Massachusetts Institute of Technology (MIT), The University of British Columbia (UBC), AlCana Technologies, Inc., and Tekmira Pharmaceuticals Corporation, presented results from multiple ongoing research efforts regarding the discovery of novel technologies for the systemic delivery of RNAi therapeutics.

10 Aug 2010

Pharmasset third-quarter net loss increases to $16.0 million

Pharmasset, Inc., a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial results and operational highlights for the quarter ended June 30, 2010.

10 Aug 2010

UT Southwestern enters partnership with Sun Yat-sen University to promote scientific research

UT Southwestern Medical Center has entered into an academic and scientific partnership with Sun Yat-sen University and its First Affiliated Hospital in Guangzhou, China. The first international institutional affiliation for UT Southwestern and a first step in implementing the global health initiative that is one of the medical center's current strategic priorities, the partnership was developed to promote joint scientific research, educational, and training activities.

10 Aug 2010

Cancer Research Technology grants Scancell licence to use 105AD7 human antibody

Scancell Holdings Plc,, the developer of therapeutic cancer vaccines, and Cancer Research Technology Ltd - Cancer Research UK's commercialisation and development arm - today announce that they have signed an agreement under which Scancell has been granted a licence to use a human antibody known as 105AD7.

10 Aug 2010

Raptor Pharmaceutical to raise $15 million through PIPE financing

Raptor Pharmaceutical Corp., announced it has entered into a securities purchase agreement in connection with a private placement, or PIPE financing. Upon the closing of the PIPE financing, Raptor will receive gross proceeds of approximately $15 million resulting from the sale of 4,897,614 units at a purchase price of $3.075 per unit.

10 Aug 2010

Texas Children's Hospital provides tips to ensure healthy and successful school year

It's August and for many families that means it's time to head back to school. From sleep schedules, nutrition, immunizations, heart health, heat illnesses and more, Texas Children's Hospital in Houston provides parents with tips to ensure their children have a safe, healthy and successful school year.

10 Aug 2010

CareView files patent for innovative technology to prevent decubitus ulcers

CareView Communications, Inc. ("CareView" or the "Company"), an information technology provider to the healthcare industry, announced that it has filed a new patent with the United States Patent and Trademark Office to cover an innovative technology that will assist hospitals and other medical facilities in their efforts to prevent decubitus ulcers or "bed sores" experienced by patients. CareView's new product covered by the pending patent uses the CareView System monitoring system to ensure timely patient movement which assists caregivers in the prevention and treatment of bed sores.

10 Aug 2010

Phase Forward second-quarter GAAP revenues increase 12% to $58.6 million

Phase Forward Incorporated today announced its financial results for the second quarter of 2010.

10 Aug 2010

Medical News

DSS research survey reveals relationship between engagements, health literacy

Surveillance systems find no major disease outbreaks since Haiti quake; Media examine aid disbursements

Olympus America introduces new V-System for ERCP procedure

Three-year efficacy data on STELARA for psoriasis presented at American Academy of Dermatology meeting

FDA approves human embryonic stem cells clinical trial for spinal cord injury treatment

Older Americans suffer from full-blown depression: Report

Survey shows web users access social media sites in emergency situations

Transcept Pharmaceuticals second-quarter net loss decreases to $2.06 million

CGI receive contract for chronic disease management system

Calif. considers reduction in funding for home care aides; Ill. union workers strike over health issues at uranium conversion plant

HHS: $250 million in grants available for New Access Points for delivery of primary health care services

Epitherix identifies potent and selective multiple chemical scaffolds against colorectal carcinoma

Alnylam Pharmaceuticals reports significant progress in discovery of novel technologies for systemic delivery of RNAi therapeutics

Pharmasset third-quarter net loss increases to $16.0 million

UT Southwestern enters partnership with Sun Yat-sen University to promote scientific research

Cancer Research Technology grants Scancell licence to use 105AD7 human antibody

Raptor Pharmaceutical to raise $15 million through PIPE financing

Texas Children's Hospital provides tips to ensure healthy and successful school year

CareView files patent for innovative technology to prevent decubitus ulcers

Phase Forward second-quarter GAAP revenues increase 12% to $58.6 million

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Latest News